UTHR
United Therapeutics Corporation · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -2.9% · nuevas posiciones netas -4.8% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 157 | +4 | 27.98M | $15.17B | +8 | −5 |
| Q1 2026 | 157 | -1 | 29.64M | $17.54B | +5 | −7 |
| Q4 2025 | 157 | +1 | 32.29M | $15.72B | +2 | n/a |
| Q3 2025 | 21 | 0 | 20.11M | $8.43B | +1 | −2 |
| Q2 2025 | 19 | 0 | 20.17M | $5.79B | n/a | n/a |
| Q1 2025 | 16 | +1 | 10.14M | $3.12B | +1 | n/a |
| Q4 2024 | 15 | 0 | 10.52M | $3.71B | +1 | −1 |
| Q3 2024 | 14 | 0 | 8.99M | $3.22B | n/a | n/a |
| Q2 2024 | 14 | n/a | 8.17M | $2.60B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 5.35M | +0.4% | $2.24B | 0.0% | ▲ Add | 2 | SEC ↗ ×22 |
| 2 | The Vanguard Group ✦ (pasivo) | 4.42M | -0.7% | $1.85B | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | Renaissance Technologies ✦ | 2.17M | +2.6% | $911.11M | 1.2% | ▲ Add | 6 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (pasivo) | 1.92M | -11.3% | $805.98M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 1.40M | -3.1% | $586.38M | 0.1% | ▼ Trim | 6 | SEC ↗ ×7 |
| 6 | Geode Capital Management ✦ (pasivo) | 1.25M | +4.1% | $522.91M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | AQR Capital Management ✦ | 986.48K | -22.5% | $413.54M | 0.3% | ▼ Trim | 6 | SEC ↗ ×4 |
| 8 | JPMorgan Chase ✦ | 495.87K | n/a | $207.88M | 0.0% | n/c | 1 | SEC ↗ ×28 |
| 9 | Morgan Stanley ✦ | 438.80K | n/a | $183.95M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 10 | T. Rowe Price ✦ | 300.93K | +162.8% | $126.15M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 11 | Citadel Advisors ✦ | 273.98K | +94.3% | $114.86M | 0.1% | ▲ Add | 4 | SEC ↗ ×2 |
| 12 | Millennium Management ✦ | 258.58K | +235.5% | $108.40M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 250.33K | -41.0% | $104.94M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 14 | Arrowstreet Capital ✦ | 208.53K | -38.5% | $87.42M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 99.78K | Nuevo | $41.83M | 0.1% | New | 1 | SEC ↗ |
| 16 | Goldman Sachs Group ✦ | 81.54K | n/a | $34.18M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 17 | Gotham Asset Management ✦ | 80.96K | -9.4% | $33.94M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 64.71K | +199.5% | $27.13M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Fisher Asset Management ✦ | 23.58K | +26.8% | $9.89M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 16.09K | +82.8% | $6.75M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 16.07K | -91.8% | $6.73M | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Point72 Asset Management | $41.83M | 0.1% |
Posición cerrada
| Norges Bank | $136.45M | era 0.0% |
| Marshall Wace | $79.45M | era 0.1% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 844 tenedores, 41.22M acciones, $23.10B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer, Director · 200 acc. · $110,143
Officer, Director · 2.17K acc. · $1.19M
Officer, Director · 281 acc. · $151,874
Officer · 268 acc. · $145,160
Officer, Director · 456 acc. · $247,462
Officer, Director · 601 acc. · $328,713
Officer, Director · 371 acc. · $201,599
Officer · 1.98K acc. · $1.08M
Officer · 791 acc. · $430,975
Officer, Director · 825 acc. · $450,347
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología